VF
CORV

Virtu Financial’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Virtu Financial’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$118K Buy
+287,972
New +$478K 0.01% 1055
2019
Q3 		– Sell
-11,529
Closed -$25K – 2020
2019
Q2 		$25K Buy
+11,529
New +$29.5K ﹤0.01% 1324
2018
Q4 		– Sell
-10,088
Closed -$41K – 2173
2018
Q3 		$41K Buy
+10,088
New +$44.5K ﹤0.01% 1326
2018
Q1 		– Sell
-11,693
Closed -$18K – 2919
2017
Q4 		$18K Sell
11,693
-15,965
-58% -$25.6K ﹤0.01% 2234
2017
Q3 		$59K Buy
+27,658
New +$94.1K ﹤0.01% 2204

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return